Literature DB >> 6265369

Genetic analysis of resistance to lethal infections of vesicular stomatitis virus in Syrian hamsters.

P N Fultz, J A Shadduck, C Y Kang, J W Streilein.   

Abstract

Vesicular stomatitis virus (VSV), Indiana serotype, causes a lethal disease in adult Syrian hamsters. Susceptibility to low doses of VSV (10 to 100 plaque-forming units) was shown to be genetically determined by examining six inbred strains. Three strains, LSH, MHA, and CB, were found to be extremely susceptible, with more than 70% of the animals dying within 72 h after intraperitoneal injection. Two strains, MIT and UT2, were intermediately susceptible, with approximately 60% of VSV-infected animals surviving. One strain, UT1, was found to be highly resistant; however, resistance was not acquired until the 4th or 5th week of age, and 100% of VSV-infected neonatal hamsters died. Analyses of F1 hybrid and segregant backcross populations derived from the LSH and UT1 strains suggested that at least three independent genetic loci contribute to phenotypic resistance. One locus resides on the X chromosome; the others reside on autosomes. No obvious linkage to the hamster major histocompatibility complex was detected. F1 hybrids of two highly susceptible strains, CB and MHA, were more resistant than either parental strain, suggesting that alleles of unlinked genes in the susceptible strains interact to produce a partially resistant phenotype. These alleles probably are the cause of the resistance phenotype found in the random-bred LVG strain which shares a common heritage with the CB and MHA strains.

Entities:  

Mesh:

Year:  1981        PMID: 6265369      PMCID: PMC351551          DOI: 10.1128/iai.32.3.1007-1013.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Cell-mediated immunity to vesicular stomatitis virus infections in mice.

Authors:  R M Zinkernagel; B Adler; J J Holland
Journal:  Exp Cell Biol       Date:  1978

2.  Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.

Authors:  R M Zinkernagel; A Althage; J Holland
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

3.  Natural cell-mediated cytotoxicity in hamsters.

Authors:  S K Datta; M T Gallagher; J J Trentin
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

4.  Proteins of vesicular stomatitis virus. I. Polyacrylamide gel analysis of viral antigens.

Authors:  C Y Kang; L Prevec
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

5.  Cell migration from the thymus to other lymphoid organs in hamsters of different ages.

Authors:  T J Linna
Journal:  Blood       Date:  1968-06       Impact factor: 22.113

6.  Differences between Syrian hamster strains in natural killer cell activity induced by infection with Pichinde virus.

Authors:  S R Gee; D A Clark; W E Rawls
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

7.  Rejection of adenovirus 2-transformed cell tumors and immune responsiveness in Syrian hamsters.

Authors:  J L Cook; C H Kirkpatrick; A S Rabson; A M Lewis
Journal:  Cancer Res       Date:  1979-12       Impact factor: 12.701

8.  Age-related and thymus-dependent rejection of adenovirus 2-transformed cell tumors in the Syrian hamster.

Authors:  J L Cook; A M Lewis; C H Kirkpatrick
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

9.  Variation between strains of hamsters in the lethality of Pichinde virus infections.

Authors:  M J Buchmeier; W E Rawls
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

10.  Genetic resistance to lethal flavivirus encephalitis. I. Infection of congenic mice with Banzi virus.

Authors:  R O Jacoby; P N Bhatt
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

View more
  10 in total

1.  Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.

Authors:  Kyle S Brown; David Safronetz; Andrea Marzi; Hideki Ebihara; Heinz Feldmann
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

2.  Murine resistance to street rabies virus: genetic analysis by testing second-backcross progeny and verification of allelic resistance genes in SJL/J and CBA/J mice.

Authors:  D L Lodmell; B Chesebro
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

3.  Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon.

Authors:  P N Fultz; J A Shadduck; C Y Kang; J W Streilein
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

4.  Involvement of cells of hematopoietic origin in genetically determined resistance of Syrian hamsters to vesicular stomatitis virus.

Authors:  P N Fultz; J A Shadduck; C Y Kang; J W Streilein
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

5.  Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus).

Authors:  Marko Zivcec; David Safronetz; Elaine Haddock; Heinz Feldmann; Hideki Ebihara
Journal:  J Immunol Methods       Date:  2011-02-17       Impact factor: 2.303

6.  Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.

Authors:  Chad E Mire; Andrew D Miller; Angela Carville; Susan V Westmoreland; Joan B Geisbert; Keith G Mansfield; Heinz Feldmann; Lisa E Hensley; Thomas W Geisbert
Journal:  PLoS Negl Trop Dis       Date:  2012-03-20

7.  Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates.

Authors:  J Erik Johnson; Farooq Nasar; John W Coleman; Roger E Price; Ali Javadian; Kenneth Draper; Margaret Lee; Patricia A Reilly; David K Clarke; R Michael Hendry; Stephen A Udem
Journal:  Virology       Date:  2006-11-13       Impact factor: 3.616

8.  Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.

Authors:  D N Yarde; S Naik; R A Nace; K-W Peng; M J Federspiel; S J Russell
Journal:  Cancer Gene Ther       Date:  2013-11-01       Impact factor: 5.987

9.  A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.

Authors:  Takeshi Saito; Junki Maruyama; Noriyo Nagata; Mao Isono; Kosuke Okuya; Yoshihiro Takadate; Yurie Kida; Hiroko Miyamoto; Akina Mori-Kajihara; Takanari Hattori; Wakako Furuyama; Shinya Ogawa; Shigeru Iida; Ayato Takada
Journal:  Viruses       Date:  2020-08-22       Impact factor: 5.048

10.  VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern.

Authors:  Kyle L O'Donnell; Tylisha Gourdine; Paige Fletcher; Kyle Shifflett; Wakako Furuyama; Chad S Clancy; Andrea Marzi
Journal:  Vaccines (Basel)       Date:  2022-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.